{
    "clinical_study": {
        "@rank": "131176", 
        "arm_group": {
            "arm_group_label": "Stage I, II, III, IV HNSCC"
        }, 
        "brief_summary": {
            "textblock": "Head and neck squamous cell carcinoma(HNSCC) is the fourth common malignancy in Taiwan. It\n      accounts for 5.8% of all cancers and causes 2,463 deaths per year. Aberrant glycosylation is\n      the hallmark of most human cancers, including HNSCC, and affects many cellular properties.\n      This study is aimed at exploring the role of mucin glycosylating enzymes in HNSCC."
        }, 
        "brief_title": "Mucin Glycosylating Enzymes in Head and Neck Cancers", 
        "completion_date": {
            "#text": "October 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Mucin Glycosylating Enzyme, HNSCC", 
        "condition_browse": {
            "mesh_term": "Head and Neck Neoplasms"
        }, 
        "detailed_description": {
            "textblock": "Glycosylation is the most common post-translational modification of proteins. Aberrant\n      glycosylation is the hallmark of most human cancers and affect many cellular properties,\n      including cell proliferation, apoptosis, differentiation, transformation, migration and\n      immune response.\n\n      Though widely explored in various human cancers, the role of mucin glycosylating enzymes in\n      HNSCC has not been elucidated. Our aims is to analyze the expression patterns of mucin\n      glycosylating enzymes in HNSCC tissues. Furthermore, we will correlate the expression levels\n      of mucin glycosylating enzymes with clinical characteristics of HNSCC patients."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Head and neck cancer patients receiving operation in National Taiwan University\n             Hospital\n\n        Exclusion Criteria:\n\n          -  Recurrence or non-operable patients"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "90 Years", 
            "minimum_age": "20 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Head and neck cancer patients receiving operation in National Taiwan University Hospital"
            }
        }, 
        "enrollment": {
            "#text": "250", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 22, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01976377", 
            "org_study_id": "201307074RIND"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "October 29, 2013", 
        "location": {
            "contact": {
                "email": "pjlou@ntu.edu.tw", 
                "last_name": "Pei-Jen Lou, MD, PhD", 
                "phone": "886-972651527"
            }, 
            "contact_backup": {
                "email": "b91401051@ntu.edu.tw", 
                "last_name": "Mei-Chun Lin", 
                "phone": "886-978261268"
            }, 
            "facility": {
                "address": {
                    "city": "Taipei", 
                    "country": "Taiwan", 
                    "zip": "100"
                }, 
                "name": "National Taiwan University"
            }, 
            "investigator": {
                "last_name": "Pei-Jen Lou, M.D, Ph.D", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Taiwan"
        }, 
        "number_of_groups": "1", 
        "official_title": "Expression of Mucin Glycosylating Enzymes in Head and Neck Cancers and Its Correlation With Clinico-pathological Parameters.", 
        "overall_contact": {
            "email": "pjlou@ntu.edu.tw", 
            "last_name": "Pei-Jen Lou, M.D, Ph.D", 
            "phone": "886-972651527"
        }, 
        "overall_contact_backup": {
            "email": "b91401051@ntu.edu.tw", 
            "last_name": "Mei-Chun Lin", 
            "phone": "886-978261268"
        }, 
        "overall_official": {
            "affiliation": "National Taiwan University Hospital", 
            "last_name": "Pei-Jen Lou, M.D, Ph.D", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Taiwan: Department of Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Measure the expression of mucin glycosylating in head and neck cancer", 
            "safety_issue": "Yes", 
            "time_frame": "1~5 years after patient received surgery"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01976377"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "National Taiwan University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Taiwan University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Observational Model: Case Control, Time Perspective: Retrospective", 
        "study_type": "Observational", 
        "verification_date": "October 2013"
    }
}